DRD2 and cancer: We anticipate that these models and specimens will drive future efforts to study how activation of D2R signalling promotes anti-angiogenic responses in the tumour microenvironment, particularly focusing on how cancer-associated fibroblasts, immune cells, stromal cells, and endothelial cells alter the tumour microenvironment to regulate tumour cell function.